Mogroside IIA1 TN1934
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Mogroside II-A1 exhibits inhibitory effects with IC50 values of 346-400 mol ratio/32 pmol TPA. and shows weak inhibitory effects on activation of (+/-)-(E)-methyl-2-[(E)-hydroxyimino]-5-nitro-6-methoxy-3-hexemide (NOR 1), a nitric oxide (NO) donor.
CAS nr:
88901-44-4
Purity:
98%
Molecular Weight:
801,01
SMILES:
[H][C@@]12CC[C@H](O)C(C)(C)C1=CC[C@@]1([H])[C@]3(C)CC[C@H]([C@H](C)CC[C@@H](O[C@@H]4O[C@H](CO[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)O)[C@@]3(C)C[C@@H](O)[C@@]21C
Formula:
C42H72O14
Pathway:
Others,Immunology/Inflammation
Target:
Others,NO Synthase
